Some studies have reported that the application of gamma-secretase inhibitor DAPT to inhibit the Notch signaling pathway can inhibit angiotensin II-induced pulmonary vascular remodeling and reduce pulmonary artery pressure [61,62,63], providing a new idea for the treatment of pulmonary hypertension. This evidence concerns the gene AGT and pulmonary hypertension.